These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

402 related articles for article (PubMed ID: 30635824)

  • 21. Walking disability measures in multiple sclerosis patients: Correlations with MRI-derived global and microstructural damage.
    Jakimovski D; Weinstock-Guttman B; Hagemeier J; Vaughn CB; Kavak KS; Gandhi S; Bennett SE; Fuchs TA; Bergsland N; Dwyer MG; Benedict RHB; Zivadinov R
    J Neurol Sci; 2018 Oct; 393():128-134. PubMed ID: 30165291
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Validation of ELISA assays for the calculation of FLC indices for the diagnosis of intrathecal immunoglobulin synthesis.
    Heim X; Hubert AM; Raouak I; Nzepa AC; Mege JL; Delmont E; Attarian S; Koric L; Pelletier J; Brodovitch A; Boucraut J
    Clin Chem Lab Med; 2023 Aug; 61(9):1623-1629. PubMed ID: 37015059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of CSF free light chain in diagnosis and prognosis of multiple sclerosis and clinically isolated syndrome: prospective cohort study in Buenos Aires.
    Sáez MS; Rojas JI; Lorenzón MV; Sánchez F; Patrucco L; Míguez J; Azcona C; Sorroche P; Cristiano E
    J Neurol; 2019 Jan; 266(1):112-118. PubMed ID: 30386877
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Kappa free light chain and neurofilament light independently predict early multiple sclerosis disease activity-a cohort study.
    Hegen H; Berek K; Bsteh G; Auer M; Altmann P; Di Pauli F; Grams A; Milosavljevic D; Ponleitner M; Poskaite P; Schnabl C; Wurth S; Zinganell A; Berger T; Walde J; Deisenhammer F
    EBioMedicine; 2023 May; 91():104573. PubMed ID: 37086651
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of sensitivities and specificities of cerebrospinal fluid free light chains to diagnose multiple sclerosis- a multicentric case-control study.
    Thevarkalam M; Krishnan S; Shanmughan LI; Mathai A; Leelamani JV; Kannoth S; Bhaskaran R; Iype T; Panda S
    Mult Scler Relat Disord; 2023 Jun; 74():104717. PubMed ID: 37062197
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of free immunoglobulin light chains in cerebrospinal fluids of patients with central nervous system lymphomas.
    Schroers R; Baraniskin A; Heute C; Kuhnhenn J; Alekseyev A; Schmiegel W; Schlegel U; Pels HJ
    Eur J Haematol; 2010 Sep; 85(3):236-42. PubMed ID: 20528903
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Free light chains in the cerebrospinal fluid: an indicator of recent immunological stimulation.
    Vakaet A; Thompson EJ
    J Neurol Neurosurg Psychiatry; 1985 Oct; 48(10):995-8. PubMed ID: 3932600
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams.
    Reiber H; Zeman D; Kušnierová P; Mundwiler E; Bernasconi L
    Clin Chim Acta; 2019 Oct; 497():153-162. PubMed ID: 31351929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunoenzymatic determination of free immunoglobulin light chains in the cerebrospinal fluid: its value in the biological diagnosis of multiple sclerosis].
    Allal C; Ghaffor M; Rabhi H; Chaouche M; Tazir M; Abbadi MC
    Arch Inst Pasteur Alger; 1989; 57():111-24. PubMed ID: 2518740
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differences in kappa to lambda (kappa:lambda) ratios of serum and urinary free light chains.
    Abe M; Goto T; Kosaka M; Wolfenbarger D; Weiss DT; Solomon A
    Clin Exp Immunol; 1998 Feb; 111(2):457-62. PubMed ID: 9486419
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Free light chains of immunoglobulins in patients with systemic sclerosis: correlations with lung involvement and inflammatory milieu.
    Bosello S; Basile U; De Lorenzis E; Gulli F; Canestrari G; Napodano C; Parisi F; Pocino K; Di Mario C; Tolusso B; Ferraccioli G; Gremese E
    J Clin Pathol; 2018 Jul; 71(7):620-625. PubMed ID: 29447111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Search for new biomarkers of pediatric multiple sclerosis: application of immunoglobulin free light chain analysis.
    Ganelin-Cohen E; Golderman S; Yeskaraev R; Rozenberg A; Livneh A; Kaplan B
    Clin Chem Lab Med; 2018 Jun; 56(7):1081-1089. PubMed ID: 29408796
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple sclerosis progression in a natural history study: predictive value of cerebrospinal fluid free kappa light chains.
    Rudick RA; Medendorp SV; Namey M; Boyle S; Fischer J
    Mult Scler; 1995 Nov; 1(3):150-5. PubMed ID: 9345445
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Serum immunoglobulin free light chain assessment in rheumatoid arthritis and primary Sjogren's syndrome.
    Gottenberg JE; Aucouturier F; Goetz J; Sordet C; Jahn I; Busson M; Cayuela JM; Sibilia J; Mariette X
    Ann Rheum Dis; 2007 Jan; 66(1):23-7. PubMed ID: 16569685
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Long-Term Storage on Serum Free Light Chain Stability.
    Hörber S; Klein R; Peter A
    Clin Lab; 2019 May; 65(5):. PubMed ID: 31115238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased cortical curvature reflects white matter atrophy in individual patients with early multiple sclerosis.
    Deppe M; Marinell J; Krämer J; Duning T; Ruck T; Simon OJ; Zipp F; Wiendl H; Meuth SG
    Neuroimage Clin; 2014; 6():475-87. PubMed ID: 25610761
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Magnetic resonance findings in the brain of patients with multiple sclerosis without oligoclonal bands in the cerebrospinal fluid].
    Mesaroc S; Drulović J; Lević Z; Perić V
    Srp Arh Celok Lek; 2003; 131(1-2):31-5. PubMed ID: 14608859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intercenter agreement of brain atrophy measurement in multiple sclerosis patients using manually-edited SIENA and SIENAX.
    Jasperse B; Valsasina P; Neacsu V; Knol DL; De Stefano N; Enzinger C; Smith SM; Ropele S; Korteweg T; Giorgio A; Anderson V; Polman CH; Filippi M; Miller DH; Rovaris M; Barkhof F; Vrenken H;
    J Magn Reson Imaging; 2007 Oct; 26(4):881-5. PubMed ID: 17896359
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Kappa Free Light Chains in the Context of Blood Contamination, and Other IgA- and IgM-Related Cerebrospinal Fluid Disease Pattern.
    Hannich MJ; Dressel A; Budde K; Petersmann A; Nauck M; Süße M
    Cells; 2021 Mar; 10(3):. PubMed ID: 33799494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kappa free light chains could predict early disease course in multiple sclerosis.
    Vecchio D; Crespi I; Virgilio E; Naldi P; Campisi MP; Serino R; Dianzani U; Bellomo G; Cantello R; Comi C
    Mult Scler Relat Disord; 2019 May; 30():81-84. PubMed ID: 30738877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.